FIELD: medicine, cardiology, chemical-pharmaceutical industry. SUBSTANCE: invention relates to agents influencing on cardiovascular system. Invention proposes agent that comprises 1-(4-phenyl-2-pyrrolidone)-acetamide and di- or triacid and it comprises alkaline metal hydroxide additionally, polyethylene oxide and water taken in the definite ratio of components. Agent comprises succinic or malic acid as diacid and citric acid as triacid. Sodium hydroxide is used as alkaline metal hydroxide. Invention provides good solubility of agent in water, it pH is near to neutral value, agent is low toxic, apyrogenic and stable in storage. EFFECT: valuable medicinal properties of agent. 4 cl, 5 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| NEW PREPARATIVE SUBSTANCE FORM CHARACTERISED BY NOOTROPIC AND NEUROMODULATING ACTIVITY, AND RELATED METHOD OF PRODUCTION | 2007 |
|
RU2327458C1 |
| AGENT FOR NORMALIZATION OF ARTERIAL BLOOD PRESSURE AND METHOD OF TREATMENT OF HYPERTENSION | 2000 |
|
RU2183117C1 |
| MEDICINAL AGENT ELICITING ANTIULCEROUS, CARDIOPROTECTIVE AND ANTISHOCK EFFECT | 2001 |
|
RU2211213C2 |
| ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
| METHOD OF PREPARING SODIUM 10-METHYLENE CARBOXYLATE-9-ACRIDONE OR 10- METHYLENECARBOXY-9-ACRIDONE FROM ACRIDONE | 1998 |
|
RU2162843C2 |
| SOLID MEDICINAL AGENT | 2001 |
|
RU2198659C1 |
| STABLE BUDESONIDE-CONTAINING AQUEOUS SOLUTION WITH ANTI-INFLAMMATORY EFFECT | 2000 |
|
RU2180217C2 |
| PHARMACEUTICAL COMPOSITION ELICITING NOOTROPIC ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240783C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
